Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory to Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06033820
What this trial is testing

Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma RecurrentDiffuse Large B Cell Lymphoma Refractory
RenJi Hospital 20
Early research (Phase 1)Study completedNCT00100672
What this trial is testing

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer

Who this might be right for
Neoplasms
INSYS Therapeutics Inc 40
Testing effectiveness (Phase 2)Study completedNCT02200757
What this trial is testing

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Who this might be right for
Metastatic Small Cell Lung Cancer
ImmunityBio, Inc. 135
Testing effectiveness (Phase 2)UnknownNCT01377298
What this trial is testing

Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital 45
Early research (Phase 1)Ended earlyNCT01904643
What this trial is testing

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT00030524
What this trial is testing

ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)Ended earlyNCT05886491
What this trial is testing

GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
Takeda 16
Testing effectiveness (Phase 2)Study completedNCT02306291
What this trial is testing

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Who this might be right for
Leukemia, Myeloid, Acute
GlycoMimetics Incorporated 91
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)WithdrawnNCT03166176
What this trial is testing

Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy

Who this might be right for
Solid Tumor
Samsung Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT02438761
What this trial is testing

PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)

Who this might be right for
Therapy-related Acute Myeloid Leukemia and Myelodysplastic SyndromeAcute Myeloid Leukemia, in Relapsede Novo Acute Myeloid Leukemia at Diagnostic
Institut Curie 10
Not applicableActive Not RecruitingNCT05417737
What this trial is testing

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025

Who this might be right for
Radiation ToxicityChemotherapeutic ToxicityChemotherapy-induced Peripheral Neuropathy+3 more
Bernardino Clavo, MD, PhD 105
Testing effectiveness (Phase 2)Ended earlyNCT02942758
What this trial is testing

Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML

Who this might be right for
Acute Myeloid Leukemia
University Hospital Regensburg 10
Testing effectiveness (Phase 2)Study completedNCT03466320
What this trial is testing

DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2

Who this might be right for
AMLMDS
Celyad Oncology SA 21
Testing effectiveness (Phase 2)Ended earlyNCT00737360
What this trial is testing

Phase II Study of TAS-106 to Treat Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Taiho Pharmaceutical Co., Ltd. 27
Early research (Phase 1)Study completedNCT01820624
What this trial is testing

Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Paolo Caimi, MD 12
Testing effectiveness (Phase 2)Study completedNCT01921673
What this trial is testing

Dovitinib Plus Docetaxel in Gastric Cancer

Who this might be right for
Gastric Cancer
Asan Medical Center 14
Not applicableLooking for participantsNCT07325851
What this trial is testing

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.

Who this might be right for
Chemotherapy-Induced Peripheral NeuropathyRadiation ToxicityChronic Pain+2 more
Bernardino Clavo, MD, PhD 120
Testing effectiveness (Phase 2)Study completedNCT00499577
What this trial is testing

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland Greenebaum Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT01626495
What this trial is testing

Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
University of Pennsylvania 73
Next Page